Your Market Access Strategy
The Pharma Partners (TPP) Healthcare is your full-service, strategic advisory firm. We serve to be the bridge that constructs and realizes successful collaborations between China and Western countries in the healthcare industry, capital market and innovation space.
We strive to expand the global healthcare network, specializing in cross-border deal flow in China’s healthcare industry. The firm is the leading platform to facilitate partnerships to fuse Chinese capital, its large and rapid growing market with US/EU healthcare innovation.
At TPP, we constantly adjust our business model to stay relevant in a changing market.
Founded in 2014, TPP spun out from Eastar Pharmaceuticals, a 30-year-old privately-owned corporation servicing the chemical and pharmaceutical industries. Its specialty focused on China-license pharmaceuticals and medical devices from small-to-medium size North American and Western Europe companies wishing to import to China.
Today we take this experience, solid network and understanding of the market to focus on launch-to-late stage patented products that fills unmet needs in China.
Service Offerings
Licensing & Business Dev.
Secure deals for your company with our unparalleled access to decision makers at the Top 100 Chinese pharmaceutical and medical technology companies.
China Profile Enhancement
Attain recognition and exposure in China through our network and services.
Equity Investments
Gain access to the most active healthcare investors in China with qualified interest in your company.
